生命科学资讯

FDA ‘proactively’ hands J&J a voucher; Pfizer issues 2026 forecasts

Enhertu combo cleared for use in frontline breast cancer

‘Zombie’ biotech buyer Xoma to acquire Generation Bio

Argenx falters in effort to expand immune drug’s use

Sanofi MS drug hits two setbacks

Kyverna to seek first clearance of a CAR-T therapy for autoimmune disease

How rare-disease teams can fine-tune COAs to bridge meaningful change and measurable progress

Sobi snaps up gout drug in $950M deal for startup Arthrosi

Arcus cancels work on Gilead-partnered cancer combo after trial setback

Praxis tees up another approval filing; Geron turns to layoffs

AC Immune posts positive data for Parkinson’s immunotherapy

Biotech venture firm Apple Tree goes bankrupt amid dispute with billionaire backer

Lilly’s three-pronged drug puts obesity field ‘on notice’

Crapo, Cassidy propose enhanced ACA subsidy alternative

Prolynx banks $70M for longer-lasting obesity drugs

FDA approves first drug in National Priority Voucher program

A former Roivant spinout bets on AI-designed drugs for immune conditions

Novartis notches another win for drug acquired in MorphoSys deal

Pfizer dips into China for another try at an obesity pill

FDA raises CAR-T approval standards; Novartis bets on an AI startup